Reuters logo
BRIEF-RXi Pharmaceuticals reports Q3 2017 financial results and recent corporate highlights
November 8, 2017 / 12:28 PM / 10 days ago

BRIEF-RXi Pharmaceuticals reports Q3 2017 financial results and recent corporate highlights

Nov 8 (Reuters) - RXi Pharmaceuticals Corp:

* Reports third quarter 2017 financial results and recent corporate highlights

* At September 30, 2017, company had cash of $5.4 million, compared with $12.9 million at December 31, 2016​

* Qtrly loss per share $0.11​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below